Subash Chandra Sonkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Subash Chandra Sonkar has a total of 205 co-authors. Here are the top co-authors by number of shared publications:
Pratima Mittal
Department of Obstetrics & Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India
10 shared publications- Daman Saluja
Dr. B.R. Ambedkar Center for Biomedical Research, University of Delhi, Delhi 110007, India
8 shared publications Daman Saluja
Delhi School of Public Health (DSPH), Institute of Eminence and Dr. B. R. Ambedkar Centre for Biomedical Research (ACBR), University of Delhi, Delhi, India
7 shared publicationsKirti Wasnik
Dr. B. R. Ambedkar Center for Biomedical Research, University of Delhi, New Delhi, India
7 shared publicationsA Kumar
Department of Obstetrics and Gynaecology, Vardhman Mahavir Medical College and Safdarjung Hospital, New, New Delhi, India
5 shared publications- Bidhan Chandra Koner
Maulana Azad Medical College (MAMC)
5 shared publications
Latest Publications
- Open Access
- 15 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 17 (2)
Diabetes: A comprehensive review of the Indian landscape in contrast with global trends
In recent years, diabetes has become a major global health concern, and India is one of the countries most affected by the growing number of cases. In this review, we explore the diabetes scenario in the Indian community in comparison with global patterns. The extensive literature on diabetes suggests that poor diet, sedentary lifestyles, and genetic predisposition have been risk factors for diabetes. We further discuss disease management and treatment strategies related to diabetes in India, highlighting the challenges in healthcare accessibility and affordability. In addition, particularly in Indian scenarios, the role of traditional medicine as an alternative medicine is also discussed. This overall highlights possible interventions, including the National Diabetes Control Program, telehealth advancements, and community-based awareness campaigns. Therefore, we aim to discuss potential scenarios like rapid urbanization, changing dietary patterns, and socio-economic disparities in the diabetes epidemic in the country, and practical solutions for overall diabetes outcomes.
- 15 February 2026
- Published by Baishideng Publishing Group Inc. in World Journal of Diabetes
- Vol. 17 (2)
Open AccessDiabetes: A comprehensive review of the Indian landscape in contrast with global trends
In recent years, diabetes has become a major global health concern, and India is one of the countries most affected by the growing number of cases. In this review, we explore the diabetes scenario in the Indian community in comparison with global patterns. The extensive literature on diabetes suggests that poor diet, sedentary lifestyles, and genetic predisposition have been risk factors for diabetes. We further discuss disease management and treatment strategies related to diabetes in India, highlighting the challenges in healthcare accessibility and affordability. In addition, particularly in Indian scenarios, the role of traditional medicine as an alternative medicine is also discussed. This overall highlights possible interventions, including the National Diabetes Control Program, telehealth advancements, and community-based awareness campaigns. Therefore, we aim to discuss potential scenarios like rapid urbanization, changing dietary patterns, and socio-economic disparities in the diabetes epidemic in the country, and practical solutions for overall diabetes outcomes.
- Open Access
- 2 February 2026
- Published by MDPI AG in Aerobiology
- Vol. 4 (1) , 5
One Network–One Nation–One Health India’s Strategic Blueprint for Resilient, Cross-Sectoral Health Systems
The escalating threats of zoonotic diseases, antimicrobial resistance (AMR), climate change, and environmental degradation have intensified the need for a unified health approach. One Health—integrating human, animal, and environmental health—is critical for national and global health security. India, with its high population density, biodiversity, and socio-ecological complexity, stands poised to lead in operationalizing this integrated vision. This review analyzes India’s evolving One Health ecosystem, focusing on policy development, inter-ministerial collaborations, surveillance systems, grassroots implementation, and education. Institutions like the National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), and Department of Biotechnology (DBT) are discussed. We propose a strategic blueprint built on integrated surveillance (One Network), cross-sectoral governance (One Nation), and field-level implementation (One Health). Highlighting successful case studies and India’s role in global platforms, the article presents a roadmap to bridge fragmented efforts into a resilient, community-driven national mission to protect human, animal, and environmental health.
- 2 February 2026
- Published by MDPI AG in Aerobiology
- Vol. 4 (1) , 5
Open AccessOne Network–One Nation–One Health India’s Strategic Blueprint for Resilient, Cross-Sectoral Health Systems
The escalating threats of zoonotic diseases, antimicrobial resistance (AMR), climate change, and environmental degradation have intensified the need for a unified health approach. One Health—integrating human, animal, and environmental health—is critical for national and global health security. India, with its high population density, biodiversity, and socio-ecological complexity, stands poised to lead in operationalizing this integrated vision. This review analyzes India’s evolving One Health ecosystem, focusing on policy development, inter-ministerial collaborations, surveillance systems, grassroots implementation, and education. Institutions like the National Centre for Disease Control (NCDC), Indian Council of Medical Research (ICMR), and Department of Biotechnology (DBT) are discussed. We propose a strategic blueprint built on integrated surveillance (One Network), cross-sectoral governance (One Nation), and field-level implementation (One Health). Highlighting successful case studies and India’s role in global platforms, the article presents a roadmap to bridge fragmented efforts into a resilient, community-driven national mission to protect human, animal, and environmental health.
- Open Access
- 31 December 2025
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 98 (4) , 431-439
A Triplex PCR Assay for Simultaneous Detection of Non-viral STDs in Both Dry and Wet Swabs, Offering a Rapid and Cost-Effective Diagnostic Tool
Sexually transmitted diseases (STDs) remain a major global public health challenge because their health consequences lead to severe complications, especially among sexually active populations. Trichomonas vaginalis (TV), Chlamydia trachomatis (CT), ...
- 31 December 2025
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 98 (4) , 431-439
Open AccessA Triplex PCR Assay for Simultaneous Detection of Non-viral STDs in Both Dry and Wet Swabs, Offering a Rapid and Cost-Effective Diagnostic Tool
Sexually transmitted diseases (STDs) remain a major global public health challenge because their health consequences lead to severe complications, especially among sexually active populations. Trichomonas vaginalis (TV), Chlamydia trachomatis (CT), ...
- Open Access
- 12 May 2025
- Published by IntechOpen
Airborne and Surface Transmission of SARS-CoV-2 in Hospital Settings: Evidence from a COVID-19 Dedicated Hospital in India
This chapter investigates the airborne and surface transmission of SARS-CoV-2 within a dedicated COVID-19 hospital in Delhi, India, during the peak of the pandemic. The study, conducted between July and September 2020, employed air and surface sampling in key hospital areas, including the intensive care unit (ICU), medicine ward, and emergency ward. Air samples were collected at 1- and 3-m distances from patients, while surface swabs were taken from high-touch areas such as patient beds, floors, and nursing stations. Reverse-transcriptase polymerase chain reaction (RT-PCR) was used to detect viral RNA. Results confirmed the presence of SARS-CoV-2 in the air up to 3 m from patients, with higher viral loads closer to the source, and widespread surface contamination, particularly on patient beds and floors. The findings highlight the dual transmission pathways of SARS-CoV-2, emphasizing the risks of airborne transmission in poorly ventilated spaces and fomite transmission on frequently touched surfaces. The study underscores the importance of robust infection control measures, including improved ventilation, the use of personal protective equipment (PPE), and regular disinfection of high-contact surfaces. These insights provide critical evidence for refining infection prevention strategies in healthcare settings, particularly in resource-limited environments, to mitigate the spread of SARS-CoV-2 and protect healthcare workers and patients.
- 12 May 2025
- Published by IntechOpen
Open AccessAirborne and Surface Transmission of SARS-CoV-2 in Hospital Settings: Evidence from a COVID-19 Dedicated Hospital in India
This chapter investigates the airborne and surface transmission of SARS-CoV-2 within a dedicated COVID-19 hospital in Delhi, India, during the peak of the pandemic. The study, conducted between July and September 2020, employed air and surface sampling in key hospital areas, including the intensive care unit (ICU), medicine ward, and emergency ward. Air samples were collected at 1- and 3-m distances from patients, while surface swabs were taken from high-touch areas such as patient beds, floors, and nursing stations. Reverse-transcriptase polymerase chain reaction (RT-PCR) was used to detect viral RNA. Results confirmed the presence of SARS-CoV-2 in the air up to 3 m from patients, with higher viral loads closer to the source, and widespread surface contamination, particularly on patient beds and floors. The findings highlight the dual transmission pathways of SARS-CoV-2, emphasizing the risks of airborne transmission in poorly ventilated spaces and fomite transmission on frequently touched surfaces. The study underscores the importance of robust infection control measures, including improved ventilation, the use of personal protective equipment (PPE), and regular disinfection of high-contact surfaces. These insights provide critical evidence for refining infection prevention strategies in healthcare settings, particularly in resource-limited environments, to mitigate the spread of SARS-CoV-2 and protect healthcare workers and patients.
- 28 April 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 211, 104751
Revolutionizing immunotherapy: The next frontier in CAR T-cell engineering
- 28 April 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 211, 104751
Revolutionizing immunotherapy: The next frontier in CAR T-cell engineering
- Open Access
- 19 December 2024
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 97 (4) , 505-514
Alkhumra Hemorrhagic Fever Virus (AHFV): A Concise Overview
Alkhumra fever is a viral disease caused by the Alkhumra hemorrhagic fever virus (AHFV). It belongs to family Flaviviridae, genus Flavivirus. AHFV is primarily transmitted to humans through the bite of infected ticks, for example, Hyalomma. This ...
- 19 December 2024
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 97 (4) , 505-514
Open AccessAlkhumra Hemorrhagic Fever Virus (AHFV): A Concise Overview
Alkhumra fever is a viral disease caused by the Alkhumra hemorrhagic fever virus (AHFV). It belongs to family Flaviviridae, genus Flavivirus. AHFV is primarily transmitted to humans through the bite of infected ticks, for example, Hyalomma. This ...
- Open Access
- 19 December 2024
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 97 (4) , 529-534
Monkeypox (Mpox): Diagnosis and Emerging Challenges
Monkeypox (Mpox) has once again been designated a Public Health Emergency of International Concern (PHEIC) as of August, 2024. The severity of the disease is underscored by its significant mortality rate, and unfortunately, there are no targeted ...
- 19 December 2024
- Published by Yale Journal of Biology and Medicine in The Yale Journal of Biology and Medicine
- Vol. 97 (4) , 529-534
Open AccessMonkeypox (Mpox): Diagnosis and Emerging Challenges
Monkeypox (Mpox) has once again been designated a Public Health Emergency of International Concern (PHEIC) as of August, 2024. The severity of the disease is underscored by its significant mortality rate, and unfortunately, there are no targeted ...
- Open Access
- 3 April 2024
- Published by Elsevier in Infectious Medicine
- Vol. 3 (2) , 100105
Insights into the emergence and evolution of monkeypox virus: Historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures
- 3 April 2024
- Published by Elsevier in Infectious Medicine
- Vol. 3 (2) , 100105
Open AccessInsights into the emergence and evolution of monkeypox virus: Historical perspectives, epidemiology, genetic diversity, transmission, and preventative measures
- 29 December 2023
- Published by IGI Global Scientific Publishing
- p. 428-456
Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Self-renewal is the most important property of stem cells. Parallel to this, cancer stem cells (CSCs) have an indefinite proliferative ability that drives tumorigenesis. The conventional treatment of cancer includes chemotherapy, radiotherapy, and surgery, which decreases the tumour size. Contrary, targeted therapy against CSCs initially does not shrink the tumour but ultimately causes tumour degeneration. Nanobiotechnology, RNA interference, microRNA are emerging fields with a vital role in targeted therapy against CSCs. The non-protein encoding microRNAs has a major role in cancer treatment since they regulate gene expression during post-transcription. RNAi technology can silence the gene of interest with potency and specificity inhibiting tumour growth. In nanoparticles-based RNA interference, nanocarriers protect RNAi molecules from immune recognition and enzymatic degradation. The cancer cell gene expression profiling using next-generation sequencing helps in understanding the underlying cancer cell mechanisms. The current chapter deals with novel concepts in the treatment of cancer. Request access from your librarian to read this chapter's full text.
- 29 December 2023
- Published by IGI Global Scientific Publishing
- p. 428-456
Cancer Stem Cells and Advanced Novel Technologies in Oncotherapy
Self-renewal is the most important property of stem cells. Parallel to this, cancer stem cells (CSCs) have an indefinite proliferative ability that drives tumorigenesis. The conventional treatment of cancer includes chemotherapy, radiotherapy, and surgery, which decreases the tumour size. Contrary, targeted therapy against CSCs initially does not shrink the tumour but ultimately causes tumour degeneration. Nanobiotechnology, RNA interference, microRNA are emerging fields with a vital role in targeted therapy against CSCs. The non-protein encoding microRNAs has a major role in cancer treatment since they regulate gene expression during post-transcription. RNAi technology can silence the gene of interest with potency and specificity inhibiting tumour growth. In nanoparticles-based RNA interference, nanocarriers protect RNAi molecules from immune recognition and enzymatic degradation. The cancer cell gene expression profiling using next-generation sequencing helps in understanding the underlying cancer cell mechanisms. The current chapter deals with novel concepts in the treatment of cancer. Request access from your librarian to read this chapter's full text.
- Open Access
- 22 August 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1200328
Development and optimization of an in-house heterologous ELISA for detection of prednisolone drug in enzyme conjugates using spacers
The introduction of spacers in coating steroid protein complexes and/or enzyme conjugates or immunogens is known to exert an influence on the sensitivity of steroid enzyme immunoassays. We investigated the impact of different homobifunctional spacers, ranging in atomic length from 3 to 10, on the sensitivity and specificity of prednisolone (PSL) enzyme immunoassays. In this study, four homo-bifunctional spacers, namely, carbohydrazide (CH), adipic acid dihydrazide (ADH), ethylene diamine (EDA), and urea (U), were incorporated between PSL and horseradish peroxidase (HRP) for preparing the enzyme conjugate with an aim to improve the sensitivity of the assay without compromising assay specificity. The assays were developed using these enzymes conjugated with antibodies raised against the PSL-21-HS-BSA immunogen. The sensitivity of the PSL assays after insertion of a bridge in the enzyme conjugate was 1.22 ng/mL, 0.59 ng/mL, 0.48 ng/mL, and 0.018 ng/mL with ADH, CH, EDA, and urea as a spacer, respectively. Among the four combinations, the PSL-21-HS-BSA-antibody with PSL-21-HS-U-HRP-enzyme conjugate gave better sensitivity and less cross-reaction. The percent recovery of PSL from the exogenously spiked human serum pools was in the range of 88.32%-102.50%. The intra and inter-assay CV% was< 8.46%. The PSL concentration was estimated in the serum samples of patients on PSL treatment. The serum PSL values obtained by this method correlated well with the commercially available kit (r2 = 0.98). The present study suggests that the nature of the spacer is related to assay sensitivity and not the spacer length.
- 22 August 2023
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1200328
Open AccessDevelopment and optimization of an in-house heterologous ELISA for detection of prednisolone drug in enzyme conjugates using spacers
The introduction of spacers in coating steroid protein complexes and/or enzyme conjugates or immunogens is known to exert an influence on the sensitivity of steroid enzyme immunoassays. We investigated the impact of different homobifunctional spacers, ranging in atomic length from 3 to 10, on the sensitivity and specificity of prednisolone (PSL) enzyme immunoassays. In this study, four homo-bifunctional spacers, namely, carbohydrazide (CH), adipic acid dihydrazide (ADH), ethylene diamine (EDA), and urea (U), were incorporated between PSL and horseradish peroxidase (HRP) for preparing the enzyme conjugate with an aim to improve the sensitivity of the assay without compromising assay specificity. The assays were developed using these enzymes conjugated with antibodies raised against the PSL-21-HS-BSA immunogen. The sensitivity of the PSL assays after insertion of a bridge in the enzyme conjugate was 1.22 ng/mL, 0.59 ng/mL, 0.48 ng/mL, and 0.018 ng/mL with ADH, CH, EDA, and urea as a spacer, respectively. Among the four combinations, the PSL-21-HS-BSA-antibody with PSL-21-HS-U-HRP-enzyme conjugate gave better sensitivity and less cross-reaction. The percent recovery of PSL from the exogenously spiked human serum pools was in the range of 88.32%-102.50%. The intra and inter-assay CV% was< 8.46%. The PSL concentration was estimated in the serum samples of patients on PSL treatment. The serum PSL values obtained by this method correlated well with the commercially available kit (r2 = 0.98). The present study suggests that the nature of the spacer is related to assay sensitivity and not the spacer length.